During the past decade, Retina Center of New Jersey conducted 18 clinical trials. In the 10-year time frame, 18 clinical trials started and 6 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 6 clinical trials were completed. i.e. 75% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Retina Center of New Jersey" #1 sponsor was "Kodiak Sciences Inc" with 4 trials, followed by "Hoffmann-La Roche" with 3 trials sponsored, "Apellis Pharmaceuticals, Inc." with 2 trials sponsored, "Genentech, Inc." with 2 trials sponsored and "Aerpio Therapeutics" with 2 trials sponsored. Other sponsors include 1 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Retina Center of New Jersey" #1 collaborator was "Regeneron Pharmaceuticals" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Retina Center of New Jersey" are "Diabetic Macular Edema" (3 trials), "Geographic Atrophy" (3 trials), "Macular Degeneration" (3 trials), "Age-Related Macular Degeneration" (1 trials) and "Age-related Macular Degeneration" (1 trials). Many other conditions were trialed in "Retina Center of New Jersey" in a lesser frequency.

Most popular intervention types in "Retina Center of New Jersey" are "Drug" (17 trials), "Other" (7 trials) and "Combination Product" (1 trials). Other intervention types were less common.

The name of intervention was led by "Sham Procedure" (6 trials), "Aflibercept" (4 trials), "KSI-301" (4 trials), "Ranibizumab" (3 trials) and "Faricimab" (2 trials). Other intervention names were less common.

The vast majority of trials in "Retina Center of New Jersey" are 18 trials for "All" genders.

Currently, there are NaN active trials in "Retina Center of New Jersey". undefined are not yet recruiting, 1 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in Retina Center of New Jersey, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Retina Center of New Jersey, 2 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 11 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".